Friday, 29 March 2024
Protide Pharmaceuticals Inc
OBB : PPMD
0.2200 15 Sep 21 00:00 | Change: 0.10 | Open: 0.2200 | High: 0.2200 | Ask: 0.3200 | Volume: 100 |
Change(%): 83.33 | Prev: 0.1200 | Low: 0.2200 | Bid: 0.2000 | Avg vol: 0 |
07:11 | 20/1/18
PharmiWeb.com
EDINBURGH, United Kingdom, January 19, 2018 (GLOBE NEWSWIRE) - NuCana plc (NASDAQ: NCNA) announced interim results today from the ABC-08 Study at the 2018 ASCO Gastrointestinal Cancer Symposium (ASCO GI) in San Francisco, CA.
more»
02:07 | 12/1/18
The Times
Protide Pharmaceuticals Inc (PPMD)'s moving averages reveal that the Tenkan line of the shares are below the Kijun-Sen line, indicating potential downward momentum building in the bearish chart.
more»
03:01 | 3/1/18
The Ledger Gazette
Baillie Gifford & Co. bought a new position in shares of NuCana in the third quarter valued at $8,266,000. Sphera Funds Management LTD.
more»
00:03 | 27/12/17
The Ledger Gazette
NuCana PLC logo Zacks Investment Research lowered shares of NuCana (NASDAQ:NCNA) from a hold rating to a sell rating in a report issued on Thursday, January 25th.
more»
01:56 | 21/11/17
PharmiWeb.com
EDINBURGH, United Kingdom, March 02, 2018 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq:NCNA), a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for cancer patients by applying its ProTide(TM) technology to ...
more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
|
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |